Jini Song

This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.

Researcher

Arkansas State University

Also affiliated: Kleijnen Systematic Reviews (United Kingdom) (2020); New York Institute of Technology (2022–2024); S.P.E.C.I.E.S. (2020)

Unknown Researcher

3 h-index 3 pubs 29 cited

Research Areas

Biomedical Subjects

Links

Lab Website

OverviewAI-generated summary

Jini Song's research focuses on understanding disease mechanisms and therapeutic strategies, particularly within the context of traditional Chinese medicine (TCM) and its application to complex conditions. Song has investigated idiopathic pulmonary hemosiderosis, reviewing current knowledge and updates in 2022. More recently, Song's work has involved network medicine analysis to dissect the therapeutic mechanisms of TCM formulas used to treat hepatocellular carcinoma (HCC), considering different TCM syndromes. This approach aims to elucidate how these complex herbal combinations interact with biological systems to combat cancer. Song's publication record includes a state-of-the-art review on idiopathic pulmonary hemosiderosis and a network medicine analysis of TCM for HCC. Song's scholarly output is characterized by an h-index of 3, with a total of 3 publications and 25 citations.

Metrics

h-index: 3
Publications: 3
Citations: 29

Selected Publications

Network medicine analysis for dissecting the therapeutic mechanism of consensus TCM formulae in treating hepatocellular carcinoma with different TCM syndromes (2024)

Frontiers in Endocrinology 5 citations DOI OpenAlex
Updates in idiopathic pulmonary hemosiderosis in 2022: A state of the art review (2022)

Pediatric Pulmonology 18 citations DOI OpenAlex
Efficacy and safety of Shufeng Jiedu capsule in the treatment of COVID-19 (2020)

Medicine 5 citations DOI OpenAlex